Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmaPrint, "major" drug firm partnering for herbals line set to debut in July.

This article was originally published in The Tan Sheet

Executive Summary

PHARMAPRINT AND "MAJOR" DRUG FIRM PARTNERING FOR HERBALS LINE of about seven supplements that will roll out to mass market retailers in July, company Chairman and CEO Elliot Friedman told securities analysts at an Oct. 2 session of the Wall Street Forum in New York City. The herbal products will be standardized, guaranteed bioavailable through PharmaPrint's eponymous patented "fingerprinting" technology and carry a pharmaceutical brand name "that everyone knows," Friedman said.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel